Videos
Up Next
0
Endo Pharmaceuticals CEO Peter Lankau
Lankau discusses earnings and the patent dispute over the generic version of oxycontin
Share
Endo Pharmaceuticals CEO Peter Lankau
Lankau discusses earnings and the patent dispute over the generic version of oxycontin
Date: 2/15/06
Views: 3
Video by:  CNBC
 
Follow us:
Today's Most Watched Videos
Related Videos
Loading... 1 of 56